Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 05, 2026
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether Intel Corporation (“Intel�
CULVER CITY, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital e
Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference
07:00am, Friday, 30'th May 2025
DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil"), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced that
Lightedge Scales Global DDoS Protection with $1.2M Corero Network Security Expansion
07:00am, Friday, 30'th May 2025
LONDON , May 30, 2025 /PRNewswire/ -- Today, Corero Network Security (AIM: CNS) (OTCQX: DDOSF) announced a $1.2 million expansion of its partnership with Lightedge, a leading provider of secure, comp
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced topline results from the Phase III clinical trial, HARMONi, the
WiseTech Global: Solid Moat And Growth Potential
05:03am, Friday, 30'th May 2025
I rate WTCHF a buy due to its strong moat, clear growth story, and transformative e2open acquisition expanding its ecosystem and monetization opportunities. CargoWise's deep integration and single glo
Kodiak Sciences to Present at 2025 Jefferies Global Healthcare Conference
09:32pm, Thursday, 29'th May 2025
PALO ALTO, Calif. , May 29, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to
Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference
04:30pm, Thursday, 29'th May 2025
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chie
RIB Software Launches Global Customer Campaign: “You See It. Together, We'll See It Through”
04:18pm, Thursday, 29'th May 2025
New campaign celebrates the people behind engineering and construction and RIB's commitment to delivering digital tools that turn vision into results. New campaign celebrates the people behind enginee
Alumis to Present at the Jefferies Global Healthcare Investor Conference
04:15pm, Thursday, 29'th May 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated
Acadia Pharmaceuticals to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
04:05pm, Thursday, 29'th May 2025
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Mond
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
04:00pm, Thursday, 29'th May 2025
WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in i
PHILADELPHIA--(BUSINESS WIRE)--With tariffs disrupting global supply chains and inflation squeezing margins, business leaders face mounting pressure to do more with less. In response, Gap Internationa
Apollo Global Management Partners With Banks to Trade Private Credit
02:30pm, Thursday, 29'th May 2025
Apollo Global Management is reportedly working with five banks, including JPMorgan Chase & Co. and Goldman Sachs Group, to trade private credit. The collaboration will enable Apollo and its partners t
Zeta Global: Finding Opportunity In Risk
01:20pm, Thursday, 29'th May 2025
Zeta Global offers strong revenue growth, expanding AI-driven platform adoption, and trades at a valuation discount, supporting a positive long-term outlook. Legal risks from past financial and data p
